Greater Cannabis Company (GCAN) Short term Debt (2016 - 2022)

Greater Cannabis Company (GCAN) recorded quarterly Short term Debt of $260000.0 in Q4 2022, little changed quarter-over-quarter from $260000.0 in Q3 2022, and little changed on a YoY basis from $260000.0 in Q4 2021.

Greater Cannabis Company (GCAN) Short term Debt (2016 - 2022) Analysis & Trends

Greater Cannabis Company's Short term Debt history runs 7 years deep, the most recent figure standing at $260000.0 for Q4 2022.

  • In Q4 2022, Short term Debt changed 0.0% year-over-year to $260000.0; the TTM figure through Dec 2022 stood at $260000.0 (changed 0.0% YoY), while the FY2022 annual figure was $260000.0, changed 0.0% from the prior year.
  • Short term Debt was $260000.0 for Q4 2022 at Greater Cannabis Company, roughly flat from $260000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.7 million in Q1 2020 to a low of $17441.0 in Q4 2020.
  • Historically, Short term Debt has averaged $324458.4 across 5 years, with a median of $260000.0 in 2018.
  • The sharpest annual moves came in 2018 and 2020: Short term Debt jumped 2730.84% in 2018, then tumbled 93.29% in 2020.
  • A 5-year view of Short term Debt shows it stood at $280310.0 in 2018, then retreated by 7.25% to $260000.0 in 2019, then sank by 93.29% to $17441.0 in 2020, then surged by 1390.74% to $260000.0 in 2021, then changed by 0.0% to $260000.0 in 2022.
  • The last three Short term Debt figures came in at $260000.0 (Q4 2022), $260000.0 (Q3 2022), and $260000.0 (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Greater Cannabis Company - - -

Historic Data

Download Data
DateValue
Dec 31, 2022 260,000.00
Sep 30, 2022 260,000.00
Jun 30, 2022 260,000.00
Mar 31, 2022 260,000.00
Dec 31, 2021 260,000.00
Sep 30, 2021 260,000.00
Jun 30, 2021 260,000.00
Mar 31, 2021 260,000.00
Dec 31, 2020 17,441.00
Sep 30, 2020 325,935.00
Jun 30, 2020 260,000.00
Mar 31, 2020 1.70 Mn
Dec 31, 2019 260,000.00
Sep 30, 2019 260,000.00
Jun 30, 2019 251,367.00
Mar 31, 2019 260,000.00
Dec 31, 2018 280,310.00
Sep 30, 2018 260,000.00
Jun 30, 2018 270,502.00
Mar 31, 2018 259,142.00